Global Cancer Angiogenesis Inhibitor Sales Market Report 2016

Global Cancer Angiogenesis Inhibitor Sales Market Report 2016

1 Cancer Angiogenesis Inhibitor Overview

1.1 Product Overview and Scope of Cancer Angiogenesis Inhibitor

1.2 Classification of Cancer Angiogenesis Inhibitor

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Cancer Angiogenesis Inhibitor

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Cancer Angiogenesis Inhibitor Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Cancer Angiogenesis Inhibitor (2011-2021)

1.5.1 Global Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2021)

1.5.2 Global Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2021)

2 Global Cancer Angiogenesis Inhibitor Competition by Manufacturers, Type and Application

2.1 Global Cancer Angiogenesis Inhibitor Market Competition by Manufacturers

2.1.1 Global Cancer Angiogenesis Inhibitor Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global Cancer Angiogenesis Inhibitor Revenue and Share by Manufacturers (2011-2016)

2.2 Global Cancer Angiogenesis Inhibitor (Volume and Value) by Type

2.2.1 Global Cancer Angiogenesis Inhibitor Sales and Market Share by Type (2011-2016)

2.2.2 Global Cancer Angiogenesis Inhibitor Revenue and Market Share by Type (2011-2016)

2.3 Global Cancer Angiogenesis Inhibitor (Volume and Value) by Regions

2.3.1 Global Cancer Angiogenesis Inhibitor Sales and Market Share by Regions (2011-2016)

2.3.2 Global Cancer Angiogenesis Inhibitor Revenue and Market Share by Regions (2011-2016)

2.4 Global Cancer Angiogenesis Inhibitor (Volume) by Application

3 USA Cancer Angiogenesis Inhibitor (Volume, Value and Sales Price)

3.1 USA Cancer Angiogenesis Inhibitor Sales and Value (2011-2016)

3.1.1 USA Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

3.1.2 USA Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

3.1.3 USA Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

3.2 USA Cancer Angiogenesis Inhibitor Sales and Market Share by Manufacturers

3.3 USA Cancer Angiogenesis Inhibitor Sales and Market Share by Type

3.4 USA Cancer Angiogenesis Inhibitor Sales and Market Share by Application

4 China Cancer Angiogenesis Inhibitor (Volume, Value and Sales Price)

4.1 China Cancer Angiogenesis Inhibitor Sales and Value (2011-2016)

4.1.1 China Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

4.1.2 China Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

4.1.3 China Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

4.2 China Cancer Angiogenesis Inhibitor Sales and Market Share by Manufacturers

4.3 China Cancer Angiogenesis Inhibitor Sales and Market Share by Type

4.4 China Cancer Angiogenesis Inhibitor Sales and Market Share by Application

5 Europe Cancer Angiogenesis Inhibitor (Volume, Value and Sales Price)

5.1 Europe Cancer Angiogenesis Inhibitor Sales and Value (2011-2016)

5.1.1 Europe Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

5.1.2 Europe Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

5.1.3 Europe Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

5.2 Europe Cancer Angiogenesis Inhibitor Sales and Market Share by Manufacturers

5.3 Europe Cancer Angiogenesis Inhibitor Sales and Market Share by Type

5.4 Europe Cancer Angiogenesis Inhibitor Sales and Market Share by Application

6 Japan Cancer Angiogenesis Inhibitor (Volume, Value and Sales Price)

6.1 Japan Cancer Angiogenesis Inhibitor Sales and Value (2011-2016)

6.1.1 Japan Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

6.1.2 Japan Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

6.1.3 Japan Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

6.2 Japan Cancer Angiogenesis Inhibitor Sales and Market Share by Manufacturers

6.3 Japan Cancer Angiogenesis Inhibitor Sales and Market Share by Type

6.4 Japan Cancer Angiogenesis Inhibitor Sales and Market Share by Application

7 India Cancer Angiogenesis Inhibitor (Volume, Value and Sales Price)

7.1 India Cancer Angiogenesis Inhibitor Sales and Value (2011-2016)

7.1.1 India Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

7.1.2 India Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

7.1.3 India Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

7.2 India Cancer Angiogenesis Inhibitor Sales and Market Share by Manufacturers

7.3 India Cancer Angiogenesis Inhibitor Sales and Market Share by Type

7.4 India Cancer Angiogenesis Inhibitor Sales and Market Share by Application

8 Southeast Asia Cancer Angiogenesis Inhibitor (Volume, Value and Sales Price)

8.1 Southeast Asia Cancer Angiogenesis Inhibitor Sales and Value (2011-2016)

8.1.1 Southeast Asia Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

8.2 Southeast Asia Cancer Angiogenesis Inhibitor Sales and Market Share by Manufacturers

8.3 Southeast Asia Cancer Angiogenesis Inhibitor Sales and Market Share by Type

8.4 Southeast Asia Cancer Angiogenesis Inhibitor Sales and Market Share by Application

9 Global Cancer Angiogenesis Inhibitor Manufacturers Analysis

9.1 Pfizer

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Cancer Angiogenesis Inhibitor Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Pfizer Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Allergan

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 127 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Allergan Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Alnylam Pharmaceuticals

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 140 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Alnylam Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 Amgen

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Aug Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Amgen Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Angstrom Pharmaceuticals

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Angstrom Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Acceleron Pharma

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Acceleron Pharma Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 Biocon

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Pharma & Healthcare Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Biocon Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 Bionomics

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Bionomics Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 CASI Pharmaceuticals

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 CASI Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 Celgene Corporation

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Celgene Corporation Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

9.11 Enzon Pharmaceuticals

9.12 Five Prime Therapeutics

9.13 Fujifilm Kyowa Kirin Biologics

9.14 Genentech

9.15 Genexine

9.16 Hetero Drugs

9.17 ImClone Systems

9.18 Intas Pharmaceuticals

9.19 Kyowa Hakko Kirin

9.20 Levolta Pharmaceuticals

9.21 Mabtech

9.22 Marsala Biotech

9.23 Neumedicines

9.24 Novartis

9.25 Oncobiologics

9.26 Onyx Pharmaceuticals

10 Cancer Angiogenesis Inhibitor Maufacturing Cost Analysis

10.1 Cancer Angiogenesis Inhibitor Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Cancer Angiogenesis Inhibitor

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Cancer Angiogenesis Inhibitor Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Cancer Angiogenesis Inhibitor Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Cancer Angiogenesis Inhibitor Market Forecast (2016-2021)

14.1 Global Cancer Angiogenesis Inhibitor Sales, Revenue Forecast (2016-2021)

14.2 Global Cancer Angiogenesis Inhibitor Sales Forecast by Regions (2016-2021)

14.3 Global Cancer Angiogenesis Inhibitor Sales Forecast by Type (2016-2021)

14.4 Global Cancer Angiogenesis Inhibitor Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Cancer Angiogenesis Inhibitor

Table Classification of Cancer Angiogenesis Inhibitor

Figure Global Sales Market Share of Cancer Angiogenesis Inhibitor by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Cancer Angiogenesis Inhibitor

Figure Global Sales Market Share of Cancer Angiogenesis Inhibitor by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure USA Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2021)

Figure China Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2021)

Figure Europe Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2021)

Figure Japan Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2021)

Figure India Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2021)

Figure Global Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2021)

Figure Global Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2021)

Table Global Cancer Angiogenesis Inhibitor Sales of Key Manufacturers (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Sales Share by Manufacturers (2011-2016)

Figure 2015 Cancer Angiogenesis Inhibitor Sales Share by Manufacturers

Figure 2016 Cancer Angiogenesis Inhibitor Sales Share by Manufacturers

Table Global Cancer Angiogenesis Inhibitor Revenue by Manufacturers (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Revenue Share by Manufacturers (2011-2016)

Table 2015 Global Cancer Angiogenesis Inhibitor Revenue Share by Manufacturers

Table 2016 Global Cancer Angiogenesis Inhibitor Revenue Share by Manufacturers

Table Global Cancer Angiogenesis Inhibitor Sales and Market Share by Type (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Sales Share by Type (2011-2016)

Figure Sales Market Share of Cancer Angiogenesis Inhibitor by Type (2011-2016)

Figure Global Cancer Angiogenesis Inhibitor Sales Growth Rate by Type (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Revenue and Market Share by Type (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Cancer Angiogenesis Inhibitor by Type (2011-2016)

Figure Global Cancer Angiogenesis Inhibitor Revenue Growth Rate by Type (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Sales and Market Share by Regions (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Sales Share by Regions (2011-2016)

Figure Sales Market Share of Cancer Angiogenesis Inhibitor by Regions (2011-2016)

Figure Global Cancer Angiogenesis Inhibitor Sales Growth Rate by Regions (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Revenue and Market Share by Regions (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of Cancer Angiogenesis Inhibitor by Regions (2011-2016)

Figure Global Cancer Angiogenesis Inhibitor Revenue Growth Rate by Regions (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Sales and Market Share by Application (2011-2016)

Table Global Cancer Angiogenesis Inhibitor Sales Share by Application (2011-2016)

Figure Sales Market Share of Cancer Angiogenesis Inhibitor by Application (2011-2016)

Figure Global Cancer Angiogenesis Inhibitor Sales Growth Rate by Application (2011-2016)

Figure USA Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

Figure USA Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

Figure USA Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

Table USA Cancer Angiogenesis Inhibitor Sales by Manufacturers (2011-2016)

Table USA Cancer Angiogenesis Inhibitor Market Share by Manufacturers (2011-2016)

Table USA Cancer Angiogenesis Inhibitor Sales by Type (2011-2016)

Table USA Cancer Angiogenesis Inhibitor Market Share by Type (2011-2016)

Table USA Cancer Angiogenesis Inhibitor Sales by Application (2011-2016)

Table USA Cancer Angiogenesis Inhibitor Market Share by Application (2011-2016)

Figure China Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

Figure China Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

Figure China Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

Table China Cancer Angiogenesis Inhibitor Sales by Manufacturers (2011-2016)

Table China Cancer Angiogenesis Inhibitor Market Share by Manufacturers (2011-2016)

Table China Cancer Angiogenesis Inhibitor Sales by Type (2011-2016)

Table China Cancer Angiogenesis Inhibitor Market Share by Type (2011-2016)

Table China Cancer Angiogenesis Inhibitor Sales by Application (2011-2016)

Table China Cancer Angiogenesis Inhibitor Market Share by Application (2011-2016)

Figure Europe Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

Figure Europe Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

Figure Europe Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

Table Europe Cancer Angiogenesis Inhibitor Sales by Manufacturers (2011-2016)

Table Europe Cancer Angiogenesis Inhibitor Market Share by Manufacturers (2011-2016)

Table Europe Cancer Angiogenesis Inhibitor Sales by Type (2011-2016)

Table Europe Cancer Angiogenesis Inhibitor Market Share by Type (2011-2016)

Table Europe Cancer Angiogenesis Inhibitor Sales by Application (2011-2016)

Table Europe Cancer Angiogenesis Inhibitor Market Share by Application (2011-2016)

Figure Japan Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

Figure Japan Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

Figure Japan Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

Table Japan Cancer Angiogenesis Inhibitor Sales by Manufacturers (2011-2016)

Table Japan Cancer Angiogenesis Inhibitor Market Share by Manufacturers (2011-2016)

Table Japan Cancer Angiogenesis Inhibitor Sales by Type (2011-2016)

Table Japan Cancer Angiogenesis Inhibitor Market Share by Type (2011-2016)

Table Japan Cancer Angiogenesis Inhibitor Sales by Application (2011-2016)

Table Japan Cancer Angiogenesis Inhibitor Market Share by Application (2011-2016)

Figure India Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

Figure India Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

Figure India Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

Table India Cancer Angiogenesis Inhibitor Sales by Manufacturers (2011-2016)

Table India Cancer Angiogenesis Inhibitor Market Share by Manufacturers (2011-2016)

Table India Cancer Angiogenesis Inhibitor Sales by Type (2011-2016)

Table India Cancer Angiogenesis Inhibitor Market Share by Type (2011-2016)

Table India Cancer Angiogenesis Inhibitor Sales by Application (2011-2016)

Table India Cancer Angiogenesis Inhibitor Market Share by Application (2011-2016)

Figure Southeast Asia Cancer Angiogenesis Inhibitor Sales and Growth Rate (2011-2016)

Figure Southeast Asia Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2011-2016)

Figure Southeast Asia Cancer Angiogenesis Inhibitor Sales Price Trend (2011-2016)

Table Southeast Asia Cancer Angiogenesis Inhibitor Sales by Manufacturers (2011-2016)

Table Southeast Asia Cancer Angiogenesis Inhibitor Market Share by Manufacturers (2011-2016)

Table Southeast Asia Cancer Angiogenesis Inhibitor Sales by Type (2011-2016)

Table Southeast Asia Cancer Angiogenesis Inhibitor Market Share by Type (2011-2016)

Table Southeast Asia Cancer Angiogenesis Inhibitor Sales by Application (2011-2016)

Table Southeast Asia Cancer Angiogenesis Inhibitor Market Share by Application (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Allergan Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Alnylam Pharmaceuticals Basic Information List

Table Alnylam Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Alnylam Pharmaceuticals Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Angstrom Pharmaceuticals Basic Information List

Table Angstrom Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Angstrom Pharmaceuticals Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Acceleron Pharma Basic Information List

Table Acceleron Pharma Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Acceleron Pharma Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Biocon Basic Information List

Table Biocon Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Biocon Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Bionomics Basic Information List

Table Bionomics Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bionomics Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table CASI Pharmaceuticals Basic Information List

Table CASI Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure CASI Pharmaceuticals Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Celgene Corporation Basic Information List

Table Celgene Corporation Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Celgene Corporation Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Enzon Pharmaceuticals Basic Information List

Table Enzon Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Enzon Pharmaceuticals Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Five Prime Therapeutics Basic Information List

Table Five Prime Therapeutics Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Five Prime Therapeutics Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Basic Information List

Table Fujifilm Kyowa Kirin Biologics Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Fujifilm Kyowa Kirin Biologics Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Genexine Basic Information List

Table Genexine Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genexine Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Hetero Drugs Basic Information List

Table Hetero Drugs Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Hetero Drugs Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table ImClone Systems Basic Information List

Table ImClone Systems Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ImClone Systems Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Intas Pharmaceuticals Basic Information List

Table Intas Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Intas Pharmaceuticals Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Kyowa Hakko Kirin Basic Information List

Table Kyowa Hakko Kirin Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Kyowa Hakko Kirin Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Levolta Pharmaceuticals Basic Information List

Table Levolta Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Levolta Pharmaceuticals Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Mabtech Basic Information List

Table Mabtech Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Mabtech Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Marsala Biotech Basic Information List

Table Marsala Biotech Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Marsala Biotech Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Neumedicines Basic Information List

Table Neumedicines Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Neumedicines Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Oncobiologics Basic Information List

Table Oncobiologics Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Oncobiologics Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Onyx Pharmaceuticals Basic Information List

Table Onyx Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Onyx Pharmaceuticals Cancer Angiogenesis Inhibitor Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cancer Angiogenesis Inhibitor

Figure Manufacturing Process Analysis of Cancer Angiogenesis Inhibitor

Figure Cancer Angiogenesis Inhibitor Industrial Chain Analysis

Table Raw Materials Sources of Cancer Angiogenesis Inhibitor Major Manufacturers in 2015

Table Major Buyers of Cancer Angiogenesis Inhibitor

Table Distributors/Traders List

Figure Global Cancer Angiogenesis Inhibitor Sales and Growth Rate Forecast (2016-2021)

Figure Global Cancer Angiogenesis Inhibitor Revenue and Growth Rate Forecast (2016-2021)

Table Global Cancer Angiogenesis Inhibitor Sales Forecast by Regions (2016-2021)

Table Global Cancer Angiogenesis Inhibitor Sales Forecast by Type (2016-2021)

Table Global Cancer Angiogenesis Inhibitor Sales Forecast by Application (2016-2021)